相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Erythropoietic regulators of iron metabolism
Tomas Ganz
FREE RADICAL BIOLOGY AND MEDICINE (2019)
Striking while the iron is hot: Iron metabolism and ferroptosis in neurodegeneration
Shashank Masaldan et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
The development of the concept of ferroptosis
Tal Hirschhorn et al.
FREE RADICAL BIOLOGY AND MEDICINE (2019)
A gene-based recessive diplotype exome scan discovers FGF6, a novel hepcidin-regulating iron-metabolism gene
Shicheng Guo et al.
BLOOD (2019)
Transferrin receptor 1 controls systemic iron homeostasis by fine-tuning hepcidin expression to hepatocellular iron load
Carine Fillebeen et al.
BLOOD (2019)
Treating Alzheimer's disease by targeting iron
Sara Nikseresht et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
The catalytic, stem, and transmembrane portions of matriptase-2 are required for suppressing the expression of the iron-regulatory hormone hepcidin
Peizhong Mao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2019)
Hepcidin and iron regulatory proteins coordinately regulate ferroportin 1 expression in the brain of mice
Lan Wang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Ferroptosis as a Novel Therapeutic Target for Friedreich's Ataxia
M. Grazia Cotticelli et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2019)
The Emerging Roles of Ferroptosis in Huntington's Disease
Yajing Mi et al.
NEUROMOLECULAR MEDICINE (2019)
The Relevancy of Data Regarding the Metabolism of Iron to Our Understanding of Deregulated Mechanisms in ALS; Hypotheses and Pitfalls
Camille Petillon et al.
FRONTIERS IN NEUROSCIENCE (2019)
Cystathionine beta-synthase is required for body iron homeostasis
Yu-Fu Zhou et al.
HEPATOLOGY (2018)
Brain iron accumulation in Wilson's disease: A longitudinal imaging case study during anticopper treatment using 7.0T MRI and transcranial sonography
Petr Dusek et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2018)
Evidence that iron accelerates Alzheimer's pathology: a CSF biomarker study
Scott Ayton et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Peroxiredoxin-2: A Novel Regulator of Iron Homeostasis in Ineffective Erythropoiesis
Alessandro Matte et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
Phenotyping rare hepcidin deficiency
Edouard Bardou-Jacquet
BLOOD (2018)
Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease
Kam Sandhu et al.
BLOOD (2018)
Clinical features and dysfunctions of iron metabolism in Parkinson disease patients with hyper echogenicity in substantia nigra: a cross-sectional study
Shu-yang Yu et al.
BMC NEUROLOGY (2018)
Advances in understanding iron metabolism and its crosstalk with erythropoiesis
Clara Camaschella et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Sustained plasma hepcidin suppression and iron elevation by Anticalin-derived hepcidin antagonist in cynomolgus monkey
Andreas M. Hohlbaum et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
CHOP induces apoptosis by affecting brain iron metabolism in rats with subarachnoid hemorrhage
Jun Zhao et al.
EXPERIMENTAL NEUROLOGY (2018)
Nano-liposomes of lycopene reduces ischemic brain damage in rodents by regulating iron metabolism
Yashuo Zhao et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Circulating iron levels influence the regulation of hepcidin following stimulated erythropoiesis
Cornel S. G. Mirciov et al.
HAEMATOLOGICA (2018)
Iron and Alzheimer's Disease: An Update on Emerging Mechanisms
Darius J. R. Lane et al.
JOURNAL OF ALZHEIMERS DISEASE (2018)
Hepcidin, an emerging and important player in brain iron homeostasis
Driton Vela
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Dietary lipophilic iron alters amyloidogenesis and microglial morphology in Alzheimer's disease knock-in APP mice
Douglas G. Peters et al.
METALLOMICS (2018)
Susceptibility MRI Captures Nigral Pathology in Patients With Parkinsonian Syndromes
Mechelle M. Lewis et al.
MOVEMENT DISORDERS (2018)
Different Characteristics of Hepcidin Expression in IL-6+/+ and IL-6-/- Neurons and Astrocytes Treated with Lipopolysaccharides
Juan Ma et al.
NEUROCHEMICAL RESEARCH (2018)
Iron released from reactive microglia by noggin improves myelin repair in the ischemic brain
Jin A. Shin et al.
NEUROPHARMACOLOGY (2018)
Unraveling the Burden of Iron in Neurodegeneration: Intersections with Amyloid Beta Peptide Pathology
Romina Maria Uranga et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2018)
The Aging of Iron Man
Azhaar Ashraf et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Circulating iron levels influence the regulation of hepcidin following stimulated erythropoiesis
Cornel S. G. Mirciov et al.
HAEMATOLOGICA (2018)
Hypoxia enhances H2O2-mediated upregulation of hepcidin: Evidence for NOX4-mediated iron regulation
Ines Silval et al.
REDOX BIOLOGY (2018)
White matter changes in Alzheimer's disease: a focus on myelin and oligodendrocytes
Sara E. Nasrabady et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2018)
CSF ferritin relationship to CSF Aβ could be used to identify AD patients for iron chelation therapy
James R. Connor
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Target identification of hepcidin production inhibitors by a combination of chemical proteomics and radioactive compound binding assay
Masato Sasaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Discovery of DS42450411 as a potent orally active hepcidin production inhibitor: Design and optimization of novel 4-aminopyrimidine derivatives
Takeshi Fukuda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2018)
Hepcidin-mediated hypoferremic response to acute inflammation requires a threshold of Bmp6/Hjv/Smad signaling
Carine Fillebeen et al.
BLOOD (2018)
Production of bioactive hepcidin by recombinant DNA tagging with an elastin-like recombinamer
A. da Costa et al.
NEW BIOTECHNOLOGY (2018)
Quantitative Susceptibility MRI to Detect Brain Iron in Amyotrophic Lateral Sclerosis
Julio Acosta-Cabronero et al.
RADIOLOGY (2018)
Impact of Inflammation on Ferritin, Hepcidin and the Management of Iron Deficiency Anemia in Chronic Kidney Disease
Norishi Ueda et al.
NUTRIENTS (2018)
Inflammation, Hemolysis, and Erythropoiesis Lead to Competitive Regulation of Hepcidin and Possibly Systemic Iron Status in Sickle Cell Disease
Yelena Z. Ginzburg et al.
EBIOMEDICINE (2018)
The Dual Role of Hepcidin in Brain Iron Load and Inflammation
Driton Vela
FRONTIERS IN NEUROSCIENCE (2018)
Erythroferrone inhibits the induction of hepcidin by BMP6
Joao Arezes et al.
BLOOD (2018)
Hepcidin upregulation by inflammation is independent of Smad1/5/8 signaling by activin B
Celine Besson-Fournier et al.
BLOOD (2017)
Brain biometals and Alzheimer's disease - boon or bane?
Atish Prakash et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2017)
Hepcidin knockout mice spontaneously develop chronic pancreatitis owing to cytoplasmic iron overload in acinar cells
Mariia Lunova et al.
JOURNAL OF PATHOLOGY (2017)
Brain Iron Metabolism Dysfunction in Parkinson's Disease
Hong Jiang et al.
MOLECULAR NEUROBIOLOGY (2017)
Expression of Iron Transporters and Pathological Hallmarks of Parkinson's and Alzheimer's Diseases in the Brain of Young, Adult, and Aged Rats
Li-Na Lu et al.
MOLECULAR NEUROBIOLOGY (2017)
Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis
Valerian E. Kagan et al.
NATURE CHEMICAL BIOLOGY (2017)
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Sebastian Doll et al.
NATURE CHEMICAL BIOLOGY (2017)
Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment
L. Poli et al.
NEUROLOGICAL SCIENCES (2017)
Brain iron accumulation in Wilson disease: a post mortem 7 Tesla MRI - histopathological study
P. Dusek et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2017)
Reciprocal regulation between hepcidin and erythropoiesis and its therapeutic application in erythroid disorders
Caiyi Wang et al.
EXPERIMENTAL HEMATOLOGY (2017)
Functional expression and purification of recombinant Hepcidin25 production in Escherichia coli using SUMO fusion technology
Vahideh Sadr et al.
GENE (2017)
Imatinib and spironolactone suppress hepcidin expression
Katarzyna Mleczko-Sanecka et al.
HAEMATOLOGICA (2017)
Aceruloplasminaemia: a disorder of diabetes and neurodegeneration
Genevieve L. Calder et al.
INTERNAL MEDICINE JOURNAL (2017)
Cortical Iron Reflects Severity of Alzheimer's Disease
Sara van Duijn et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Interleukin-1β (IL-1β) transcriptionally activates hepcidin by inducing CCAAT enhancer-binding protein δ (C/EBP δ) expression in hepatocytes
Yohei Kanamori et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Iron transport proteins: Gateways of cellular and systemic iron homeostasis
Mitchell D. Knutson
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Iron homeostasis: An anthropocentric perspective
Richard Coffey et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway
Mastura Wahedi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Hepcidin attenuates amyloid beta-induced inflammatory and pro-oxidant responses in astrocytes and microglia
Pamela J. Urrutia et al.
JOURNAL OF NEUROCHEMISTRY (2017)
Hepcidin: a real-time biomarker of iron need
Dominic J. Hare
METALLOMICS (2017)
Non-Anticoagulant Heparins Are Hepcidin Antagonists for the Treatment of Anemia
Maura Poli et al.
MOLECULES (2017)
Targeting iron metabolism in drug discovery and delivery
Bart J. Crielaard et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
Ferroptosis and cell death mechanisms in Parkinson's disease
Stephanie J. Guiney et al.
NEUROCHEMISTRY INTERNATIONAL (2017)
The novel multitarget iron chelating and propargylamine drug M30 affects APP regulation and processing activities in Alzheimer's disease models
Tamar Amit et al.
NEUROPHARMACOLOGY (2017)
Hepcidin is regulated by promoter-associated histone acetylation and HDAC3
Sant-Rayn Pasricha et al.
NATURE COMMUNICATIONS (2017)
Imatinib and spironolactone suppress hepcidin expression
Katarzyna Mleczko-Sanecka et al.
HAEMATOLOGICA (2017)
Serum Hepcidin Levels, Iron Dyshomeostasis and Cognitive Loss in Alzheimer's Disease
Zohara Sternberg et al.
AGING AND DISEASE (2017)
Impairment of Hepcidin Upregulation by Lipopolysaccharide in the Interleukin-6 Knockout Mouse Brain
Fa-Li Zhang et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
Identification of Antibody and Small Molecule Antagonists of Ferroportin-Hepcidin Interaction
Sandra L. Ross et al.
FRONTIERS IN PHARMACOLOGY (2017)
Hepcidin Protects Neuron from Hemin-Mediated Injury by Reducing Iron
Yu-Fu Zhou et al.
FRONTIERS IN PHYSIOLOGY (2017)
Drug Development Based on the Metals Hypothesis of Alzheimer's Disease
Ashley I. Bush
JOURNAL OF ALZHEIMERS DISEASE (2017)
Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease
Antonio Martin-Bastida et al.
SCIENTIFIC REPORTS (2017)
Hepcidin: Homeostasis and Diseases Related to Iron Metabolism
Cadiele Oliana Reichert et al.
ACTA HAEMATOLOGICA (2017)
Deletion of BMP6 worsens the phenotype of HJV-deficient mice and attenuates hepcidin levels reached after LPS challenge
Chloe Latour et al.
BLOOD (2017)
The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes
Silvia Colucci et al.
BLOOD (2017)
Cerebral quantitative susceptibility mapping predicts amyloid-β-related cognitive decline
Scott Ayton et al.
BRAIN (2017)
Endogenous hepcidin and its agonist mediate resistance to selected infections by clearing non-transferrin-bound iron
Deborah Stefanova et al.
BLOOD (2017)
Smad1/5 is required for erythropoietin-mediated suppression of hepcidin in mice
Chia-Yu Wang et al.
BLOOD (2017)
Erythroferrone and matriptase-2 independently regulate hepcidin expression
Sharraya Aschemeyer et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
A Red Carpet for Iron Metabolism
Martina U. Muckenthaler et al.
CELL (2017)
Progesterone receptor membrane component-1 regulates hepcidin biosynthesis
Xiang Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Iron and Neurodegeneration: Is Ferritinophagy the Link?
Giorgio Biasiotto et al.
MOLECULAR NEUROBIOLOGY (2016)
Review: Insights into molecular mechanisms of disease in neurodegeneration with brain iron accumulation: unifying theories
C. E. Arber et al.
NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2016)
Modulation of hepcidin to treat iron deregulation: potential clinical applications
Nicole L. Blanchette et al.
EXPERT REVIEW OF HEMATOLOGY (2016)
Regulation of Hepcidin by Erythropoiesis: The Story So Far
Sant-Rayn Pasricha et al.
ANNUAL REVIEW OF NUTRITION, VOL 36 (2016)
A diagnostic approach for neurodegeneration with brain iron accumulation: clinical features, genetics and brain imaging
Rubens Paulo Araujo Salomao et al.
ARQUIVOS DE NEURO-PSIQUIATRIA (2016)
Autophagy promotes ferroptosis by degradation of ferritin
Wen Hou et al.
AUTOPHAGY (2016)
Minihepcidin peptides as disease modifiers in mice affected by β-thalassemia and polycythemia vera
Carla Casu et al.
BLOOD (2016)
Mechanisms of ferroptosis
Jennifer Yinuo Cao et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Toll-Like Receptor 4/MyD88-Mediated Signaling of Hepcidin Expression Causing Brain Iron Accumulation, Oxidative Injury, and Cognitive Impairment After Intracerebral Hemorrhage
Xiao-Yi Xiong et al.
CIRCULATION (2016)
Neurodegeneration with Brain Iron Accumulation
Susanne A. Schneider
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2016)
Pre-treatment of rats with ad-hepcidin prevents iron-induced oxidative stress in the brain
Jing Gong et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
Iron Homeostasis in Health and Disease
Raffaella Gozzelino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Transforming Growth Factor β1 (TGF-β1) Activates Hepcidin mRNA Expression in Hepatocytes
Simeng Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Iron metabolism and related genetic diseases: A cleared land, keeping mysteries
Pierre Brissot et al.
JOURNAL OF HEPATOLOGY (2016)
Role of iron in neurodegenerative diseases
Kai Li et al.
JOURNAL OF NEURAL TRANSMISSION (2016)
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
Abdel A. Belaidi et al.
JOURNAL OF NEUROCHEMISTRY (2016)
Iron chelation in the treatment of neurodegenerative diseases
Petr Dusek et al.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2016)
Nucleic acid oxidative damage in Alzheimer's disease-explained by the hepcidin-ferroportin neuronal iron overload hypothesis?
Tim Hofer et al.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2016)
Iron and the liver
Antonello Pietrangelo
LIVER INTERNATIONAL (2016)
Regulated necrosis: disease relevance and therapeutic opportunities
Marcus Conrad et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
Ferroptosis, a newly characterized form of cell death in Parkinson's disease that is regulated by PKC
Bruce Do Van et al.
NEUROBIOLOGY OF DISEASE (2016)
Laser ablation-inductively coupled plasma-mass spectrometry imaging of white and gray matter iron distribution in Alzheimer's disease frontal cortex
Dominic J. Hare et al.
NEUROIMAGE (2016)
Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer's Disease
Joana S. Cristovao et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)
Magnetic Resonance Imaging Features of the Nigrostriatal System: Biomarkers of Parkinson's Disease Stages?
Lucie Hopes et al.
PLOS ONE (2016)
Disrupted iron homeostasis causes dopaminergic neurodegeneration in mice
Pavle Matak et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease
Alexander R. Bogdan et al.
TRENDS IN BIOCHEMICAL SCIENCES (2016)
Transferrin Receptor 2 Dependent Alterations of Brain Iron Metabolism Affect Anxiety Circuits in the Mouse
Rosa Maria Pellegrino et al.
SCIENTIFIC REPORTS (2016)
NCOA4 Deficiency Impairs Systemic Iron Homeostasis
Roberto Bellelli et al.
CELL REPORTS (2016)
Pharmacological Targeting of the Hepcidin/Ferroportin Axis
Giada Sebastiani et al.
FRONTIERS IN PHARMACOLOGY (2016)
Multimodal MRI Evaluation of the MitoPark Mouse Model of Parkinson's Disease
Linlin Cong et al.
PLOS ONE (2016)
Aspirin down Regulates Hepcidin by Inhibiting NF-κB and IL6/JAK2/STAT3 Pathways in BV-2 Microglial Cells Treated with Lipopolysaccharide
Wan-Ying Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Neurodegeneration with Brain Iron Accumulation: Genetic Diversity and Pathophysiological Mechanisms
Esther Meyer et al.
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, VOL 16 (2015)
An overview of molecular basis of iron metabolism regulation and the associated pathologies
Bruno Silva et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)
Thiol-derivatized minihepcidins retain biological activity
Eileen Fung et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2015)
Ceruloplasmin activity and iron chelation treatment of patients with Parkinson's disease
Guillaume Grolez et al.
BMC NEUROLOGY (2015)
Expression and cellular localization of hepcidin mRNA and protein in normal rat brain
Ruma Raha-Chowdhury et al.
BMC NEUROSCIENCE (2015)
Hepcidin and iron disorders: new biology and clinical approaches
J. Arezes et al.
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY (2015)
Regulation of Iron Metabolism by Hepcidin under Conditions of Inflammation
Paul J. Schmidt
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Neurodegenerative diseases and therapeutic strategies using iron chelators
Roberta J. Ward et al.
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY (2015)
Insights on the interaction of alpha-synuclein and metals in the pathophysiology of Parkinson's disease
Eleonora Carboni et al.
METALLOMICS (2015)
Insights into the Antimicrobial Properties of Hepcidins: Advantages and Drawbacks as Potential Therapeutic Agents
Lisa Lombardi et al.
MOLECULES (2015)
Is early-life iron exposure critical in neurodegeneration?
Dominic J. Hare et al.
NATURE REVIEWS NEUROLOGY (2015)
The relationship between iron dyshomeostasis and amyloidogenesis in Alzheimer's disease: Two sides of the same coin
Douglas G. Peters et al.
NEUROBIOLOGY OF DISEASE (2015)
Inflammation, Iron, Energy Failure, and Oxidative Stress in the Pathogenesis of Multiple Sclerosis
Lukas Haider
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2015)
The iron-regulatory hormone hepcidin: A possible therapeutic target?
Luc Rochette et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Hepcidin Suppresses Brain Iron Accumulation by Downregulating Iron Transport Proteins in Iron-Overloaded Rats
Fang Du et al.
MOLECULAR NEUROBIOLOGY (2015)
Symposium: Neurodegeneration with Brain Iron Accumulation
Hiroaki Miyajima
NEUROPATHOLOGY (2015)
Targeting mitochondrial metal dyshomeostasis for the treatment of neurodegeneration
Jeffrey R. Liddell
NEURODEGENERATIVE DISEASE MANAGEMENT (2015)
Bone Morphogenetic Proteins as Regulators of Iron Metabolism
Nermi L. Parrow et al.
ANNUAL REVIEW OF NUTRITION, VOL 34 (2014)
Activity of Potent and Selective Host Defense Peptide Mimetics in Mouse Models of Oral Candidiasis
Lisa K. Ryan et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Targeting Chelatable Iron as a Therapeutic Modality in Parkinson's Disease
David Devos et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Brain Iron Homeostasis: From Molecular Mechanisms To Clinical Significance and Therapeutic Opportunities
Neena Singh et al.
ANTIOXIDANTS & REDOX SIGNALING (2014)
Alzheimer's disease therapeutics targeted to the control of amyloid precursor protein translation: Maintenance of brain iron homeostasis
Sanghamitra Bandyopadhyay et al.
BIOCHEMICAL PHARMACOLOGY (2014)
The liver: conductor of systemic iron balance
Delphine Meynard et al.
BLOOD (2014)
Regulation of Ferroptotic Cancer Cell Death by GPX4
Wan Seok Yang et al.
CELL (2014)
Modulation of Hepcidin as Therapy for Primary and Secondary Iron Overload Disorders Preclinical Models and Approaches
Paul J. Schmidt et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2014)
Iron dysregulation in Huntington's disease
Michelle Muller et al.
JOURNAL OF NEUROCHEMISTRY (2014)
The role of iron in brain ageing and neurodegenerative disorders
Roberta Ward et al.
LANCET NEUROLOGY (2014)
Lipopolysaccharides Upregulate Hepcidin in Neuron via Microglia and the IL-6/STAT3 Signaling Pathway
Zhong-Ming Qian et al.
MOLECULAR NEUROBIOLOGY (2014)
Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
Jose Pedro Friedmann Angeli et al.
NATURE CELL BIOLOGY (2014)
The role of iron and reactive oxygen species in cell death
Scott J. Dixon et al.
NATURE CHEMICAL BIOLOGY (2014)
Iron in multiple sclerosis: roles in neurodegeneration and repair
Erin Stephenson et al.
NATURE REVIEWS NEUROLOGY (2014)
MRI for Iron Mapping in Alzheimer's Disease
Christian Langkammer et al.
NEURODEGENERATIVE DISEASES (2014)
The pathophysiology and pharmacology of hepcidin
Piotr Ruchala et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2014)
Hepcidin antagonists for potential treatments of disorders with hepcidin excess
Maura Poli et al.
FRONTIERS IN PHARMACOLOGY (2014)
Mammalian Iron Homeostasis in Health and Disease: Uptake, Storage, Transport, and Molecular Mechanisms of Action
Alfons Lawen et al.
ANTIOXIDANTS & REDOX SIGNALING (2013)
Regulation of systemic iron homeostasis
Karin E. Finberg
CURRENT OPINION IN HEMATOLOGY (2013)
Huntington's disease and Huntington's disease-like syndromes: an overview
Felix Goevert et al.
CURRENT OPINION IN NEUROLOGY (2013)
A convenient luminescence assay of ferroportin internalization to study its interaction with hepcidin
Ge Song et al.
FEBS JOURNAL (2013)
Metallostasis in Alzheimer's disease
Scott Ayton et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Targeting dysregulation of brain iron homeostasis in Parkinson's disease by iron chelators
Orly Weinreb et al.
FREE RADICAL BIOLOGY AND MEDICINE (2013)
Manipulation of the hepcidin pathway for therapeutic purposes
Eileen Fung et al.
HAEMATOLOGICA (2013)
The Small Molecule, Genistein, Increases Hepcidin Expression in Human Hepatocytes
Aileen W. Zhen et al.
HEPATOLOGY (2013)
The Metal Theory of Alzheimer's Disease
Ashley I. Bush
JOURNAL OF ALZHEIMERS DISEASE (2013)
Increased Iron Levels and Decreased Tissue Integrity in Hippocampus of Alzheimer's Disease Detected in vivo with Magnetic Resonance Imaging
Erika P. Raven et al.
JOURNAL OF ALZHEIMERS DISEASE (2013)
Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells
Pamela Urrutia et al.
JOURNAL OF NEUROCHEMISTRY (2013)
Neonatal E. Coli Infection Causes Neuro-Behavioral Deficits Associated with Hypomyelination and Neuronal Sequestration of Iron
Jacqueline C. Lieblein-Boff et al.
JOURNAL OF NEUROSCIENCE (2013)
Iron metabolism in the CNS: implications for neurodegenerative diseases
Tracey A. Rouault
NATURE REVIEWS NEUROSCIENCE (2013)
Is R2* a New MRI Biomarker for the Progression of Parkinson's Disease? A Longitudinal Follow-Up
Miguel Ulla et al.
PLOS ONE (2013)
Abnormal iron homeostasis and neurodegeneration
Barry B. Muhoberac et al.
FRONTIERS IN AGING NEUROSCIENCE (2013)
The systemic iron-regulatory proteins hepcidin and ferroportin are reduced in the brain in Alzheimer's disease
Animesh Alexander Raha et al.
ACTA NEUROPATHOLOGICA COMMUNICATIONS (2013)
Hepcidin and iron homeostasis
Tomas Ganz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2012)
Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis
Emilio Ramos et al.
BLOOD (2012)
Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia
Antonella Nai et al.
BLOOD (2012)
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon et al.
CELL (2012)
Efficient oxidative folding and site-specific labeling of human hepcidin to study its interaction with receptor ferroportin
Xiao Luo et al.
FEBS JOURNAL (2012)
Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export
Peng Lei et al.
NATURE MEDICINE (2012)
Designing antimicrobial peptides: form follows function
Christopher D. Fjell et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Novel Therapeutic Approach for Neurodegenerative Pathologies: Multitarget Iron-Chelating Drugs Regulating Hypoxia-Inducible Factor 1 Signal Transduction Pathway
Orly Weinreb et al.
NEURODEGENERATIVE DISEASES (2012)
Hepcidin and the Iron-Infection Axis
Hal Drakesmith et al.
SCIENCE (2012)
The pantheon of the fallen: why are there so many forms of cell death?
Douglas R. Green et al.
TRENDS IN CELL BIOLOGY (2012)
Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice
Karin E. Finberg et al.
BLOOD (2011)
Comparison of changes in gene expression of transferrin receptor-1 and other iron-regulatory proteins in rat liver and brain during acute-phase response
Ihtzaz Ahmed Malik et al.
CELL AND TISSUE RESEARCH (2011)
Hepcidin Directly Inhibits Transferrin Receptor 1 Expression in Astrocytes via a Cyclic AMP-Protein Kinase A Pathway
Fang Du et al.
GLIA (2011)
Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload
Gloria C. Preza et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Hepcidin in human iron disorders: Therapeutic implications
Antonello Pietrangelo
JOURNAL OF HEPATOLOGY (2011)
Brain iron metabolism and its perturbation in neurological diseases
Robert R. Crichton et al.
JOURNAL OF NEURAL TRANSMISSION (2011)
Combined R2*and Diffusion Tensor Imaging Changes in the Substantia Nigra in Parkinson's Disease
Guangwei Du et al.
MOVEMENT DISORDERS (2011)
The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics
Eric Karran et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Disorders associated with systemic or local iron overload: from pathophysiology to clinical practice
Giada Sebastiani et al.
METALLOMICS (2011)
Hepcidin Is Involved in Iron Regulation in the Ischemic Brain
Hui Ding et al.
PLOS ONE (2011)
Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease
James A. Duce et al.
CELL (2010)
Role of hepcidin in murine brain iron metabolism
S. -M. Wang et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
Mechanisms of brain iron transport: insight into neurodegeneration and CNS disorders
Eric Mills et al.
FUTURE MEDICINAL CHEMISTRY (2010)
PBT2 Rapidly Improves Cognition in Alzheimer's Disease: Additional Phase II Analyses
Noel G. Faux et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Unraveling of the E-helices and Disruption of 4-Fold Pores Are Associated with Iron Mishandling in a Mutant Ferritin Causing Neurodegeneration
Martin A. Baraibar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice
Sara Gardenghi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Expression of iron-related genes in human brain and brain tumors
Milla M. Hanninen et al.
BMC NEUROSCIENCE (2009)
Altered Iron Metabolism Is Part of the Choroid Plexus Response to Peripheral Inflammation
F. Marques et al.
ENDOCRINOLOGY (2009)
The iron regulatory hormone hepcidin reduces ferroportin 1 content and iron release in H9C2 cardiomyocytes
Xiao Hu Ge et al.
JOURNAL OF NUTRITIONAL BIOCHEMISTRY (2009)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial (vol 7, pg 779, 2008)
L. Lannfelt et al.
LANCET NEUROLOGY (2009)
Chelation Therapy for Neurodegenerative Diseases
Silvia Bolognin et al.
MEDICINAL RESEARCH REVIEWS (2009)
Lipopolysaccharide induces a significant increase in expression of iron regulatory hormone hepcidin in the cortex and substantia nigra in rat brain
Qin Wang et al.
ENDOCRINOLOGY (2008)
Iron-mediated Aggregation and a Localized Structural Change Characterize Ferritin from a Mutant Light Chain Polypeptide That Causes Neurodegeneration
Martin A. Baraibar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Midbrain iron content in early Parkinson disease - A potential biomarker of disease status
W. R. Wayne Martin et al.
NEUROLOGY (2008)
Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease:: a phase IIa, double-blind, randomised, placebo-controlled trial
Lars Lannfelt et al.
LANCET NEUROLOGY (2008)
Brain iron metabolism: Neurobiology and neurochemistry
Ya Ke et al.
PROGRESS IN NEUROBIOLOGY (2007)
Iron dysregulation in Alzheimer's disease: Multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents
Silvia Mandel et al.
PROGRESS IN NEUROBIOLOGY (2007)
The transferrin receptor part II: Targeted delivery of therapeutic agents into cancer cells
Tracy R. Daniels et al.
CLINICAL IMMUNOLOGY (2006)
Is ferroportin-hepcidin signaling altered in restless legs syndrome?
Stacey L. Clardy et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2006)
Distribution of the iron-regulating protein hepcidin in the murine central nervous system
S. Zechel et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2006)
Longitudinal assessment of Alzheimer's β-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging
Niels Braakman et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2006)
The crucial role of metal ions in neurodegeneration: the basis for a promising therapeutic strategy
A Gaeta et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Effects of development and iron status on ceruloplasmin expression in rat brain
YZ Chang et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2005)
Age-dependent and iron-independent expression of two mRNA isoforms of divalent metal transporter 1 in rat brain
Y Ke et al.
NEUROBIOLOGY OF AGING (2005)
Hepcidin excess induces the sequestration of iron and exacerbates tumor-associated anemia
S Rivera et al.
BLOOD (2005)
Neurodegenerative disease and iron storage in the brain
M Thomas et al.
CURRENT OPINION IN NEUROLOGY (2004)
Constitutive hepcidin expression prevents iron overload in a mouse model of hemochromatosis
G Nicolas et al.
NATURE GENETICS (2003)
Iron misregulation in the brain: a primary cause of neurodegenerative disorders
Y Ke et al.
LANCET NEUROLOGY (2003)
Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: A novel therapy for Parkinson's disease
D Kaur et al.
NEURON (2003)
Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.
SJ Hayflick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Ironing out Parkinson's disease: is therapeutic treatment with iron chelators a real possibility?
D Kaur et al.
AGING CELL (2002)
Transferrin/transferrin receptor-mediated drug delivery
HY Li et al.
MEDICINAL RESEARCH REVIEWS (2002)
The role of the transferrin-transferrin-receptor system in drug delivery and targeting
HY Li et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2002)
Recent advances in disorders of iron metabolism: mutations, mechanisms and modifiers
CN Roy et al.
HUMAN MOLECULAR GENETICS (2001)
A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome
B Zhou et al.
NATURE GENETICS (2001)
Lack of hepcidin gene expression and severe tissue iron overload in upstream stimulatory factor 2 (USF2) knockout mice
G Nicolas et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Hepcidin, a urinary antimicrobial peptide synthesized in the liver
CH Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload
C Pigeon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Brain iron transport and neurodegeneration
ZM Qian et al.
TRENDS IN MOLECULAR MEDICINE (2001)
Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice
T LaVaute et al.
NATURE GENETICS (2001)
A novel mammalian iron-regulated protein involved in intracellular iron metabolism
S Abboud et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
A Donovan et al.
NATURE (2000)
A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation
AT McKie et al.
MOLECULAR CELL (2000)
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
A Krause et al.
FEBS LETTERS (2000)
分享论文
